Neonatal Screening: Cost-utility Analysis for Galactosemia
Background: Galactosemia is a congenital metabolic disorder that can damage the health of a newborn. Screening is an important step to prevent and treat this condition. Due to increasing health care costs and limited financial resources of health systems, the most suitable economic analysis tool sho...
Saved in:
Main Authors: | Nahid HATAM (Author), Mehrdad ASKARIAN (Author), Samad SHIRVANI (Author), Elham SIAVASHI (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Avaliação econômica em saúde: triagem neonatal da galactosemia Newborn screening for galactosemia: a health economics evaluation
by: José Simon Camelo Junior, et al.
Published: (2011) -
The Discovery of GALM Deficiency (Type IV Galactosemia) and Newborn Screening System for Galactosemia in Japan
by: Atsuo Kikuchi, et al.
Published: (2021) -
The Prevalence and Clinical Study of Galactosemia Disease in a Pilot Screening Program of Neonates, Southern Iran
by: B Tarami, et al.
Published: (2011) -
The Prevalence and Clinical Study of Galactosemia Disease in a Pilot Screening Program of Neonates, Southern Iran
by: S Senemar, et al.
Published: (2011) -
Financial Burden of Inappropriate Vancomycin Use for Patients With Cancer
by: Nahid Hatam, et al.
Published: (2021)